GENE ONLINE|News &
Opinion
Blog

Antibody-Drug Conjugate
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
First Made-in-Singapore Antibody-Drug Conjugate Approved to Enter Clinical Trials
2023-01-09
Following Amgen, Hummingbird Jumps Onto Synaffix’s ADC Platform In $150 Million Licensing Deal
2023-01-06
ImmunoGen Wins FDA Accelerated Approval For Ovarian Cancer Drug
2022-11-16
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
Everest and Gilead Announce Positive Phase 3 Results of Breast Cancer Drug
2022-06-06
FDA Grants AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Its Fifth Breakthrough Label
2022-04-28
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
Sparx Therapeutics to Build a Massive Manufacturing Plant in China for Multi-Specific Antibody Production
2021-07-10
BMS Initiates Global Partnership to Advance Eisai’s First ADC to Market
2021-06-20
As BIO 2021 Approaches, Taiwan’s DCB Reveals Competitive Bio-Innovations to Watch Out For
2021-06-11
Gilead’s Breast Cancer Drug that Came off a $21 Billion Buyout Finally Gets FDA’s Full Approval
2021-04-09
ASH2020: VelosBio’s ROR1 Targeted Therapy Shines in Safety Trial
2020-12-09
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
1 2
LATEST
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
3D Printed Brain Model Could Aid in Neurosurgery
2023-03-31
Latest Study on Neuronal Gene Expression May Shed Light on the Memory Formation Process
2023-03-30
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Scroll to Top